| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A RAT by Another Name: 21st Century Cures Act and Stem Cell Therapies
|
Riley, Margaret F.
|
|
2018
|
44 |
2-3 |
p. 291-308
|
artikel
|
| 2 |
Expansion of the Priority Review Voucher Program Under the 21st Century Cures Act: Implications for Innovation and Public Health
|
Sinha, Michael S.
|
|
2018
|
44 |
2-3 |
p. 329-341
|
artikel
|
| 3 |
Fast-Forward to the Frightening Future: How the 21st Century Cures Act Accelerates Technological Innovation…at Unknown Risk to Us All
|
Orlando, Anthony W.
|
|
2018
|
44 |
2-3 |
p. 253-268
|
artikel
|
| 4 |
How the 21st Century Cures Act Can Mitigate the Ever Growing Problem of Mass Incarceration
|
Bard, Jennifer S.
|
|
2018
|
44 |
2-3 |
p. 387-402
|
artikel
|
| 5 |
Massachusetts Approves Mass. Eye & Ear and Partners HealthCare Merger
|
Melvin, Kendahl L.
|
|
2018
|
44 |
2-3 |
p. 475-478
|
artikel
|
| 6 |
New and Improved? 21st Century Cures Act Revisions to Certificates of Confidentiality
|
Wolf, Leslie E.
|
|
2018
|
44 |
2-3 |
p. 343-358
|
artikel
|
| 7 |
Off-Label Marketing's Audiences: The 21st Century Cures Act and the Relaxation of Standards for Evidence-Based Therapeutic and Cost-Comparative Claims
|
Halabi, Sam F.
|
|
2018
|
44 |
2-3 |
p. 181-196
|
artikel
|
| 8 |
Practice-Based Research Networks and the Mandate for Real-World Evidence
|
Hall-Lipsy, Elizabeth
|
|
2018
|
44 |
2-3 |
p. 219-236
|
artikel
|
| 9 |
Preface: The 21st Century Cures Act—A Cure for the 21st Century?
|
Okoro, Andrea-Gale O.
|
|
2018
|
44 |
2-3 |
p. 155
|
artikel
|
| 10 |
Real-World Data Analytics Fit for Regulatory Decision-Making
|
Schneeweiss, Sebastian
|
|
2018
|
44 |
2-3 |
p. 197-217
|
artikel
|
| 11 |
Real-World Evidence in the Real World: Beyond the FDA
|
Krause, Joan H.
|
|
2018
|
44 |
2-3 |
p. 161-179
|
artikel
|
| 12 |
21st Century Citizen Pharma: The FDA & Patient-Focused Product Development
|
Paradise, Jordan
|
|
2018
|
44 |
2-3 |
p. 309-327
|
artikel
|
| 13 |
21st Century Cures Act and Medical Device Regulation Departure from Principles or Catching the Wave
|
Kinney, Eleanor D.
|
|
2018
|
44 |
2-3 |
p. 269-290
|
artikel
|
| 14 |
21st Century Cures for the Opioid Crisis: Promise, Impact, and Missed Opportunities
|
Beletsky, Leo
|
|
2018
|
44 |
2-3 |
p. 359-385
|
artikel
|
| 15 |
The Challenge of Regulating Clinical Decision Support Software After 21st Century Cures
|
Evans, Barbara
|
|
2018
|
44 |
2-3 |
p. 237-251
|
artikel
|
| 16 |
The Evolution of Federal Regulation of Human Drugs in the United States: An Historical Essay
|
Hutt, Peter B.
|
|
2018
|
44 |
2-3 |
p. 403-451
|
artikel
|
| 17 |
The Growing Importance of Mental Health Parity
|
Scarbrough, Jessica A.
|
|
2018
|
44 |
2-3 |
p. 453-474
|
artikel
|
| 18 |
The 21st Century Cures Potpourri: Was It Worth the Price?
|
Kassirer, Jerome P.
|
|
2018
|
44 |
2-3 |
p. 157-160
|
artikel
|
Tijdschrift beschrijving